Meta AnalysisID 5516

维生素B6与结直肠癌风险的相关性:系统评价与Meta分析

CRD42022352776

Previous meta-analyses investigating the relationship between vitamin B6 and colorectal cancer incidence have included a relatively small number of original studies, and in recent years an increasing number of original s

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
5516
Evidence Id
14074
Core Evidence Id
14074
Source Meta Analysis Id
5501
Herb2 Meta Analysis Id
HBMA005501
Crd Id
CRD42022352776
Title
Association between vitamin B6 and the risk of colorectal cancer: a systemic review and meta-analysis
Review Question
Previous meta-analyses investigating the relationship between vitamin B6 and colorectal cancer incidence have included a relatively small number of original studies, and in recent years an increasing number of original studies have been published that have reached the opposite conclusion. Therefore, we started a new meta-analysis to draw more accurate conclusions
Study Type Included
Case-control studies or cohort studies
Condition Being Studied
Colorectal cancer, currently the third most common cancer in the world, imposes a severe burden on the world's health system. Researchers around the world are currently looking for ways to prevent colorectal cancer. Vitamin B6 is a common vitamin in our life and exists in a variety of daily foods. Pyridoxine 5-phosphate (PLP) is the main active coenzyme form of vitamin B6 and is involved in nearly 100 enzymatic reactions. Therefore, low vitamin B6 levels may increase the risk of colorectal cancer through aberrations in DNA synthesis, repair, and methylation. Vitamin B6 may also inhibit colorectal cancer development by reducing cell proliferation, angiogenesis, oxidative stress, inflammation, and nitric oxide synthesis.
Participant
Studies were included in the meta analysis if they met the following criteria: (1) they were cohort studies or case-control studies; (2) the exposure of interest was intake of vitamin B6 or blood (plasma or serum) levels of PLP; (3) the outcome of interest was the incidence of colorectal, colon, or rectal cancer; and (4) relative risk (RR) or odds ratio (OR) estimates with 95 % confidence intervals (95 % CI) were reported.
Animal
Human Disease Modelled
Intervention
High vitamin B6 intake or high Pyridoxine 5-phosphate in blood
Comparator Control
Low vitamin B6 intake or low Pyridoxine 5-phosphate in blood.
Main Outcome
Incidence of colorectal cancer. Measures of effect Pooled relative risk (RR) and 95% confidence interval (CI) were generated through random-effects model.
Outcome Measure
Additional Outcome
None.
Study Method
Meta-analysis, Systematic review
Keyword
Colorectal Neoplasms; Humans; Risk Factors; Vitamin B 6
Contact
jianxiong lai [email protected]
Organisational Affiliation
The Third Hospital of Mianyang (Sichuan Mental Health Center)
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-08-11
Registration Date
2022-08-22
Anticipated Start Date
2022-08-11
Anticipated Completion Date
2022-11-30
Title Cn
维生素B6与结直肠癌风险的相关性:系统评价与Meta分析
Title En
Association between vitamin B6 and the risk of colorectal cancer: a systemic review and meta-analysis
Bilingual Status
complete